This article is more than 5 years old. Information may no longer be current.
Olympus Biotech names Oliver Burckhardt president
Click Here to Manage Email Alerts
Olympus Biotech has announced via company release the appointment of Oliver Burckhardt to the position of president of Olympus Biotech Corporation. In his new role, Burckhardt will reportedly lead the company's North American business and focus on expanding opportunities for the emerging regenerative medicine market. Burckhardt will also become a member of the Olympus Biotech Board of Directors.
"The Vision of Olympus Biotech to advance into regenerative medicine is the next logical step in the treatment of many medical pathologies and conditions,” Burckhardt stated in the release. “I am excited about the overall strategic thinking and the assets that are already in place, within Olympus, which represent a perfect starting point for this future oriented strategy. I look forward to joining the talented team at Olympus Biotech and leveraging my experience in the industry to generate further growth and success.”
Before joining Olympus Biotech, Burckhardt most recently served as the international president and CEO of Scient'x Corp in Paris, France. Burckhardt also served as president of Orthofix Inc., where he was reportedly responsible for the global spine business unit.